FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
Zepbound, Mounjaro shortages are resolved, FDA confirms
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...
FDA keeps Mounjaro off shortage list after reevaluation
The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...
FDA says knockoff versions of weight loss drug must come off the market
Specialty pharmacies and online companies were selling the off-brand copies while there was a shortage of Zepbound and Mounjaro.
HealthDay on MSN3h
FDA Says Shortage of GLP-1 Tirzepatide Is Over
The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the ...
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli ...
FDA: Knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...
MedPage Today6h
FDA Says Compounded Tirzepatide Must Exit the Market
Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...
Becker's Hospital Review16h
FDA reaffirms end of Mounjaro shortage
FDA resolves two-year shortage of Mounjaro and Zepbound after pushback from compounding pharmacies. Lawsuit filed, but agency reaffirms decision.